Heather Bresch, who was called before Congress last year to explain why EpiPen's price had soared by nearly 500 percent over seven years, tells Norah O'Donnell why a competing product on the market doesn't necessarily bring prices down.
From: http://www.cbsnews.com/videos/mylan-ceo-says-brand-competition-doesnt-drive-drug-prices-down/
No comments:
Post a Comment